CGTX - Cognition Therapeutics Inc. (CGTX) CEO Lisa Ricciardi on Q4 2021 Results - Earnings Call Transcript

Cognition Therapeutics, Inc. (CGTX) Q4 2021 Earnings Call March 30, 2022 08:00 AM ET Company Participants Daniel Kontoh-Boateng - Investor Relations Lisa Ricciardi - President and Chief Executive Officer Jim O'Brien - Chief Financial Officer Tony Caggiano - Chief Medical Officer and Head of R&D Conference Call Participants Mayank Mamtani - B. Riley Securities Presentation Operator 00:04 Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2021 Earnings Conference Call. My name is Olivia and I will be your conference operator today. This call is being recorded. 00:18 I would now like to turn the presentation over to your speaker host for today's call, Mr. Daniel Kontoh-Boateng, Investor Relations for Cognition Therapeutics. Please proceed. Daniel Kontoh-Boateng 00:36 Good morning and thank you for participating in Cognition Therapeutics conference call today. With me today are Lisa Ricciardi, President and Chief Executive Officer of Cognition;

For further details see:

Cognition Therapeutics, Inc. (CGTX) CEO Lisa Ricciardi on Q4 2021 Results - Earnings Call Transcript